Replies to post #108354 on Amarin Corp Plc (AMRN)

[couldbebetter]

Looking Good. Thank you, Sam. Novartis gained around $10 billion in market cap on an injectable anti-inflammatory biologic. Certainly bodes well for R-I results not to mention its myriad modes of action, low cost, and safety profile. What BP would not be interested. If AMRN had a value of $10 billion, the price would be around $28.50.